Synthetic Drug Threats in the United States: 2018 Update

Similar documents
Drug Threats in the United States: 2019 Update

Primer on Synthetic Opioids I/S Brian Dempsey

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Trends in Opioid Availability and Abuse DEA Philadelphia Field Division April 2018

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Forensic Toxicology Findings in DRDs. Dr Hazel Torrance Manager of the Forensic Toxicology Service Forensic Medicine and Science

Substances under Surveillance

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Drug Trends &Trafficking I/S Brian Dempsey

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Data Tables

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Data Tables

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

WEDINOS Headlines 6,452. wedinos.org 5,806 BULLETIN. Samples. received. Samples. received. Samples. analysed. Samples. rejected

National Drug Early Warning System (NDEWS) Texas Sentinel Community Site Appendix Data Tables, 2015 NDEWS Coordinating Center

The EU Early Warning System: 20 years of monitoring New Psychoactive Substances in Europe

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Los Angeles County Sentinel Community Site Appendix Data Tables, 2015

Fentanyls. Reference materials LGC Quality ISO 9001 ISO/IEC ISO Guide 34 GMP/GLP ISO ISO/IEC 17043

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

61 st CND session 5(a) Changes in the scope of control of substances - Control Regimes -

39 th Expert Committee on Drug Dependence Process and recommendations

Trend Report: Q Synthetic Cannabinoids in the United States

Conventional and emerging drugs of abuse: the current situation

SmartNotes. Why test for synthetic cannabinoids? Synthetic Cannabinoids Facts

SEWPROF Roundtable Spain

Subject Matter Analysis. Novel Psychoactive Substances Legislative and Regulatory Update

A handful of dangerous new legal drugs has public health experts worried

Analytic Techniques Utilisedfor Drug Checking

E/CN.7/2015/CRP.10 * * 9 December English only V (E) * The present document is reproduced in the form in which it was received.

Heroin/Fentanyl/Cocaine Related Deaths in Cuyahoga County

wedinos.org WEDINOS Headlines 6,056 Synthetic Cannabinoid Receptor Agonists and the Law 5,058

New psychoactive substances in Belgium: current status

Fentanils in Europe: perspective from the EU EWS

SUBSTANCE MISUSE PROGRAMME. Drug deaths in Wales 2017

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Chicago Metro Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

The Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015

Ethyl Alcohol. Phencyclidine (PCP) PCP Analogs Phenethylamines/ Piperazines Tryptamines. Halogenated Helium Hydrocarbon Nitrous Oxide

wedinos.org WEDINOS Headlines 5,300 Cathinones 4, Substances BULLETIN Samples received Samples analysed Samples rejected

EXPANDED MAINE DRUG DEATH REPORT FOR 2017 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview

Proposal for a COUNCIL DECISION

Philadelphia Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

Heroin/Fentanyl/Cocaine Related Deaths in Cuyahoga County

Drug Checking: l esperienza ed i dati. Alberto SALOMONE

THE EXPANDING REACH OF THE DESIGNER DRUG MOVEMENT IN 2011: CHALLENGES FOR FORENSIC TOXICOLOGY & CHEMISTRY

Palm Beach County Substance Awareness Coalition. Drug Abuse Trends In Palm Beach County, Florida Annual Report: July 2017

Results from the STRIDA project. Matilda Bäckberg PhD, M.Sc.Pharm The Swedish Poisons Information Centre

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

BULLETIN. This quarter (October 2015 to December 2015) Samples. analysed. 53 Samples pending. f 41. Samples. rejected

Novel psychoactive substances in postmortem toxicology. Pirkko Kriikku, PhD Forensic Toxicologist

International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on

Los Angeles County Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

(U) Cocaine/Fentanyl Combination in Pennsylvania

Southeastern Florida (Miami Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

Texas Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled

Denver Metro Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

Ecstasy and Related Drugs Reporting System: 2016 Findings

Clinical Toxicology: An Update

This form should be completed and sent to:

National Drug Early Warning System (NDEWS,

The South Florida Report June 2013

The Challenges of Analytical Method Validation for Hallucinogens and Designer Stimulants in Biological Samples Using LC-TOF

NPS New Psychoactive Substances

EXPANDED MAINE DRUG DEATH REPORT FOR 2016 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview

Changing patterns of new and emerging psychoactive substances in Australia

Forensic Toxicology Scope of Testing and Detection Limits

Community Epidemiology Report November 2014

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4

Drugs and The Internet

Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled

GLOBAL S MART UPDATE. Understanding the synthetic drug market: the NPS factor VOLUME 19. March

Pharmacology of Valinate and tert-leucinate Synthetic Cannabinoids 5F- AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA,

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Flakka : The Truth Behind the Latest Designer Drug Media Storm. Donna Papsun, MS, D-ABFT-FT Forensic Toxicologist, NMS Labs

DRUGS AND THE INTERNET

D. Europe. 1. Major developments

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drugs and harmful use of alcohol 3.3 Ending the AIDS epidemic and

Miami Dade County Substance Abuse Trends and Needs Assessment 2017

Wayne County (Detroit Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

SPICE Prevention Issues Measures in Switzerland in the fight against new drugs such as SPICE and bath salts

Annual report 2012: the state of the drugs problem in Europe

The law is changing. wedinos.org. WEDINOS Headlines 4,824 3, Substances identified in either combination or isolation.

BEFORE THE UNITED STATES OF AMERICA DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION COMMENTS OF THE AMERICAN HERBAL PRODUCTS ASSOCIATION

A review of the collision induced dissociation fragmentation and the metabolism of synthetic cathinone derivatives

Thermo Scientific TruNarc Handheld Narcotics Analyzer

Lima - Peru, August 18-22, 2014

Drug Trends and Trafficking in Montana and Beyond

Recent developments in the detection of harms arising from the use of synthetic cathinonesin Europe

Trends and Patterns of Amphetamine-type Stimulants and New Psychoactive Substances

25 Most Frequently Identified Drugs * NFLIS Laboratories. Disclosure. Objectives. Deadly in Design: New (Novel) Psychoactive Substances Update

Illicit Opioid and Methamphetamine Trends in Maine

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Transcription:

Synthetic Drug Threats in the United States: 2018 Update JILL M. HEAD SPECIAL TESTING AND RESEARCH LABORATORY DRUG ENFORCEMENT ADMINISTRATION

Objectives 1. Overview of the DEA Emerging Trends & Reference Materials Programs 2. Emerging Threat Report data for CY2017 3. Synthetic opioid seized drug composition 4. Drug Monograph and FTIR Instrument Library Updates

Emerging Trends and Reference Material Programs 1. Analysis of domestic and foreign drug seizures 2. Research and method development for identification and quantitation 3. Authentication of reference materials 4. Structural Elucidation of unknown drugs 5. Authors SWGDRUG monographs 6. Monitors past/current trends to predict future needs 7. Publishes Emerging Threat Report

Emerging Threats New Psychoactive Substances (NPS) A new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the UN drug conventions, but which may pose a public health threat Synthetic Cannabinoids Substituted Cathinones Hallucinogens Synthetic Opioids Benzodiazepines Plant-Derived Highs

Forensic Chemistry Analysis WHAT IT IS Seized drug samples Parent drug WHAT IT IS NOT Biological samples Toxicological samples Metabolites

Data Sources DEA Reporting Laboratory Information Management System (LIMS) Seized: 01/01/2017 12/31/2017, Analyzed by 12/31/2017 Considerations Backlogs Availability of reference materials Excludes analyses performed at DEA Special Testing and Research Laboratory

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM PX-1 PB-22 FUB-PB-22 FUB-AKB48 5F-EMB-PINACA 5F-AB-PINACA SDB-005 NM2201 FUB-144 AB-PINACA 5F-AKB48 5F-AMB MDMB-FUBINACA ADB-CHMINACA AB-CHMINACA 5F-UR-144 AB-FUBINACA MMB-CHMICA ADB-FUBINACA 5F-MDMB-PINACA FUB-AMB 1 1 1 1 1 1 2 2 3 4 5 6 8 10 11 12 24 40 Synthetic Cannabinoids Seized and Identified by DEA between January 1, 2017 to December 31, 2017 922 synthetic cannabinoid identifications FUB-AMB was the most reported synthetic cannabinoid (51%) 21 different substances seized and identified One new substance identified 112 207 470 Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2017 through 12/31/2017 that were analyzed by 12/31/2017. The data was retrieved on 01/08/2018.

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM N-Ethylbuphedrone 1 MMMP 1 Methylone 1 3,4-Methylenedioxy-α-PBP 1 4F-α-PHP 1 4Cl-α-PPP 1 4-MMC 2 4Cl-α-PVP 2 α-ppp 3 4-CMC 3 4-Methyl-α-ethylaminopentiophenone 3 TH-PVP 6 α-php 7 Ethylone 14 Pentylone 17 α-pvp 20 4-CEC 21 Dibutylone N-Ethylpentylone Synthetic Cathinones Seized and Identified by DEA between January 1, 2017 to December 31, 2017 369 synthetic cathinone identifications N-Ethylpentylone was the most reported cathinone (54%) 19 different substances seized and identified 3 cathinones seized and identified for the first time 64 201 Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2017 through 12/31/2017 that were analyzed by 12/31/2017. The data was retrieved on 01/08/2018.

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM Synthetic Opioids Seized in 2015 Valeryl fentanyl 1 4-ANPP 8 β-hydroxythiofentanyl 12 Butyrylfentanyl 15 Acetylfentanyl 132 Fentanyl 524 Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2015 through 12/31/2015 that were analyzed by 12/31/2016. The data was retrieved on 01/04/2017.

Fentanyl-type substances Acetyl fentanyl Fentanyl Butyryl fentanyl Valeryl fentanyl (Pentanoyl fentanyl)

Synthetic Opioid Synthesis 4-ANPP Precursor + 4-ANPP Propionyl chloride Fentanyl Acetyl fentanyl Fentanyl Butyryl fentanyl Valeryl fentanyl (Pentanoyl fentanyl)

Synthetic Opioid Synthesis 4-ANPP Precursor + 4-ANPP Propionyl chloride Fentanyl + 4-ANPP 2-Furoyl chloride Furanyl Fentanyl

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM Acetyl norfentanyl 1 3-Methylfentanyl 2 p-fluorobutyrylfentanyl 3 Benzylfentanyl 3 o-fluorofentanyl 4 Valerylfentanyl 10 Opioid & Fentanyl-like CY 2016 Identifications 15 different substances seized and identified in 2016 ~60% of these substances were seized and reported for the first time in 2016 Butyryl fentanyl Acryl fentanyl Carfentanil 4-Fluoroisobutyrylfentanyl 4-ANPP 13 13 17 20 32 U-47700 50 Acetylfentanyl 112 Furanyl fentanyl 142 Fentanyl 877 Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2016 through 12/31/2016 that were analyzed by 12/31/2016. The data was retrieved on 01/04/2017.

Synthetic Opioid Synthesis Modified 4-ANPP Precursor + + Fentanyl NPP Aniline 4-ANPP Propionyl chloride Methyl + + 3-Methyl fentanyl Modified 4-ANPP Modified NPP

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM Benzoylbenzyl fentanyl 2-Thiofuranyl fentanyl U-48800 Benzylfentanyl U-49900 THF Fentanyl 3-Methylfentanyl Butyryl fentanyl Acryl fentanyl Methoxyacetylfentanyl Cyclopropylfentanyl Acetylfentanyl Carfentanil 4-FiBF ANPP U-47700 Furanyl fentanyl Fentanyl 1 1 4 4 5 6 10 25 43 49 50 59 70 74 81 186 Synthetic Opioids Seized and Identified by DEA in CY2017 284 ~117% increase in identifications in CY2017 18 different substances seized and identified 7 substances seized and identified for the first time Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2017 through 12/31/2017 that were analyzed by 12/31/2017. The data was retrieved on 01/08/2018. 1873

Synthetic Opioids A LOOK AT SEIZED DRUG MIXTURES

Mid-Atlantic Region: 17 synthetic opioid identifications Fentanyl (15) Fentanyl only (6) Fentanyl and heroin (9) with tramadol (3) with methamphetamine (1) with 4-fluoroisobutyryl and 2-furanyl fentanyl (1) Other synthetic opioids (2) 2-furanyl fentanyl (1) 2-methoxyacetyl fentanyl (1) Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits analyzed 10/15/2017 through 10/28/2017.

Southeastern Region: 12 synthetic opioid identifications Fentanyl (11) Fentanyl only (1) Fentanyl and 2-methoxyacetylfentanyl (1) Fentanyl and heroin (9) Fentanyl and heroin only (2) with ketamine (3) also with tramadol (2) with acetylfentanyl and gabapentin (1) with U-47700 (1) with an unconfirmed substance (1) Other synthetic opioids (1) 2-furanyl fentanyl and heroin Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits analyzed 10/15/2017 through 10/28/2017.

North Central Region: 18 synthetic opioid identifications Fentanyl (17) Fentanyl only (6) Fentanyl and heroin (11) Fentanyl and heroin only (8) with ketamine (1) with cocaine (1) with acrylfentanyl (1) Other synthetic opioids (1) 2-furanyl fentanyl, heroin, carfentanil Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits analyzed 10/15/2017 through 10/28/2017.

Northeastern Region: 76 synthetic opioid identifications Fentanyl (63) Fentanyl only (31) with tramadol (5) also with acetylfentanyl (1); also with ketamine (1) with 4-ANPP (2) with methorphan (1) Fentanyl and heroin (24) Fentanyl and heroin (12) with tramadol (7) also with ketamine (1); also with cocaine (1) with cocaine (1) with acetyl fentanyl (1) with U-47700 and 2-furanyl fentanyl (1) with methamphetamine (1) with butyryl fentanyl, 2-furanyl fentanyl, U-47700, and ADB-FUBINACA (1) Other synthetic opioids (13) 4-fluoroisobutyryl fentanyl (4) also with heroin (2) 2-furanyl fentanyl (4) acetylfentanyl (3) also with fentanyl (1) Cyclopropyl fentanyl (1) Butyryl fentanyl (1) Notes: This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits analyzed 10/15/2017 through 10/28/2017.

Southwestern Region: 6 synthetic opioid identifications Fentanyl (5) Representing ~19kg Other (1) 4-ANPP (1) Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits analyzed 10/15/2017 through 10/28/2017.

Southwestern Region: 20 synthetic opioid identifications Fentanyl (20) Fentanyl only (16) with Tramadol (3) with Heroin (1) Other synthetic opioids (0) Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits analyzed 11/12/2017 through 11/25/2017.

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM Benzodiazepines Benzofurans Phenazepam 3 6-APB 1 Diclazepam 3 5-MAPB 7 Flubromazolam 4 Flubromazepam 9 5-EAPB 8 Etizolam 43 Tryptamines Hallucinogens 5-MeO-MiPT 1 DOB 1 4-AcO-DMT 1 2C-B 2 5-MeO-DMT 2 25C-NBOMe 2 4-OH-MET 2 DOC 4 25I-NBOMe 4 Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2017 through 12/31/2017 that were analyzed by 12/31/2017. The data was retrieved on 01/08/2018.

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM Other Substances Seized and Identified in CY2017 Substance Unconfirmed 53 3-Methoxy-PCP 17 Mitragynine 10 3-Fluorophenmetrazine 7 Methoxetamine 7 Deschloroketamine 6 DMAA 4 2-Oxo-PCE 3 Methoxphenidine 3 4-FA 2 Notes: 1) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 01/01/2017 through 12/31/2017 that were analyzed by 12/31/2017. The data was retrieved on 01/08/2018.

299 Drug Monographs created by the Special Testing and Research Laboratory Newer monographs will only include references used in the authentication of that reference material (no links to external sites) 41 new monographs published in 2017: Deschloroketamine N-Methyl-1-(6-methylpyridin-2-yl)propan-2-amine Midazolam 4-estren-3,17-dione Flubromazolam 3-desoxy-3,4-methylenedioxypyrolvalerone 5-Fluoropentyl-3-pyridinoylindole Nandrolone undecanoate N-tert-butyl-3,4-methylenedioxycathinone 4-Methyl-alpha-ethylaminopentiophenone Tetrahydrofuran fentanyl para-fluorobutyryl fentanyl alpha-ethyltryptamine Yangonin Isobutyryl fentanyl Hexanoyl fentanyl ADB-FUBINACA EMB-FUBINACA 3-Bromomethcathinone Diclazepam 3-Chloromethcathinone 6-methoxy methylone Phenylpiracetam Phenmetrazine 4-Fluoromethylphenidate N-ethyl-N-methyl-1,2-diphenylethanamine N-(2-Methoxyethyl)-3,4-methylenedioxyamphetamine 4-Fluoropentedrone 4-Methoxy-phencyclidine Barbital Testosterone Caproate alpha-ppp Bupropion N,N-Dimethylpentylone 3-Fluorophenmetrazine Crotonyl fentanyl Benzoylbenzyl fentanyl

SWGDRUG FTIR Instrument Library: Update Version 1.6 - Updated in December 3, 2017 Over 200 compounds All compounds are authenticated RMs from DEA Mostly emerging drug type compounds Addition of all classes of controlled substances in the future Downloadable library available in different formats

Thank You! Jill M. Head Supervisory Chemist United States Drug Enforcement Administration Special Testing and Research Laboratory Jill.M.Head@usdoj.gov 703-668-3349